APA (7th ed.) Citation

Fernández-de-las-Peñas, C., Franco-Moreno, A., Ruiz-Ruigómez, M., Arrieta-Ortubay, E., Ryan-Murua, P., Lumbreras-Bermejo, C., . . . Torres-Macho, J. (2024). Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms? Viruses (1999-4915), 16(6), 947. https://doi.org/10.3390/v16060947

Chicago Style (17th ed.) Citation

Fernández-de-las-Peñas, César, et al. "Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?" Viruses (1999-4915) 16, no. 6 (2024): 947. https://doi.org/10.3390/v16060947.

MLA (9th ed.) Citation

Fernández-de-las-Peñas, César, et al. "Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?" Viruses (1999-4915), vol. 16, no. 6, 2024, p. 947, https://doi.org/10.3390/v16060947.